IREN's $15 Billion Build-Out Meets a Wall of Trimmed Price Targets
Published on 11/13/2026 at 15:42 | Editorial boerse-global.de
IREN's ambitious expansion plans are running into a more skeptical Wall Street, as a wave of price-target cuts and a downgrade underscore growing unease about the timeline and funding behind the company's build-out. CCB International moved first on Tuesday, cutting its rating from "Outperform" to "Neutral" with a US$40 price target — a call that landed alongside the company's quarterly results and its revised construction schedule.
The stock shed 1.1% on the day, extending a slide that began Tuesday as analysts trimmed their targets and investors digested persistent questions about deadlines and financing needs.
A $15 Billion Bill and a $6 Billion Gap
At the heart of the concern is the capital required to fund the plan. IREN pegged its remaining planned investments for fiscal 2027 at US$15 billion, a figure that includes US$6 billion in targeted financing whose completion hinges on market conditions. That combination — a hefty spending commitment paired with funding that isn't yet locked in — has given analysts plenty to chew on.
The company also pushed back a milestone it had described as fully contracted and financed: more than US$4 billion in annualized recurring revenue. Originally targeted for the end of 2026, the goal now points to January 2027, with a possible slip into February. IREN attributed the delay to a design change requested by Microsoft and the timing of equipment deliveries from suppliers. Reuters reported on November 6 that some infrastructure shipments for Microsoft had fallen behind schedule.
Should investors sell immediately? Or is it worth buying IREN?
Cloud Revenue Surges, but Losses Mount
The operational picture is more encouraging. In the first quarter of fiscal 2027, IREN posted revenue of US$228 million, up 66% from the prior quarter. Its AI Cloud segment did the heavy lifting, with revenue climbing 182% quarter-over-quarter to US$200 million. Bitcoin mining contributed US$28 million, and adjusted EBITDA came in at US$66 million.
The bottom line, however, remains deep in the red: IREN reported a net loss of US$263 million for the quarter.
The Analyst Scorecard
Not every house is backing away. JPMorgan kept its "Overweight" rating on the stock, with analyst Richard Choe reaffirming the call. Cantor Fitzgerald, meanwhile, slashed its price target from $99 to $47 on November 6 while maintaining its own "Overweight" stance. Two other research houses cut their targets that same day to a range of $30 to $65, holding their respective "Neutral" and "Buy" ratings.
IREN at a turning point? This analysis reveals what investors need to know now.
The split verdict leaves IREN in familiar territory: a company with signed contracts and a funded growth story, but one whose execution timeline — and the capital needed to hit it — remains the open question for the market.
Ad
IREN Stock: New Analysis - 13 November
Fresh IREN information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
